Effect of Chickpea Protein Hydrolysate Supplementation on Muscle Damage and Inflammatory Plasma Markers During a Football Tournament: A Randomized, Placebo-Controlled Crossover Trial

This randomized, placebo-controlled crossover study evaluated the safety and potential beneficial effects of a beverage containing chickpea protein hydrolysate in football players. Participants received the chickpea protein hydrolysate beverage and a matched protein-containing placebo beverage during two four-week intervention periods separated by a two-week washout period. The study assessed biochemical safety parameters, antioxidant status, inflammatory biomarkers, lipid profile, lipid peroxidation, muscle damage markers, dietary intake, and body composition.

NCT Number	NCT07765719
Lead Sponsor	Instituto de la Grasa Collaborators: Universidad Pablo de Olavide, CDTI (Centro para el Desarrollo Tecnologico Industrial), Ministerio de Ciencia e Innovacion, Spain, Instituto de Biomedicina (IBiS) de Sevilla
Conditions	Post-Exercise Recovery
Enrollment	51 participants
Start Date	2022-02-14
Primary Completion	2022-05-17 (estimated)
Study Completion	2022-05-17 (estimated)
Updated on ClinicalTrials.gov	2026-08-14